(Q42970742)

12 November 2017

Atorvastatin and cardiac hypertrophy and function in hypertrophic cardiomyopathy: a pilot study (English)

1 reference

hypertrophic cardiomyopathy

12 November 2017

1 reference

Sherif F Nagueh

1

1 reference

12 November 2017

Raffaella Lombardi

2

1 reference

12 November 2017

Yanli Tan

3

1 reference

12 November 2017

Jianwen Wang

4

1 reference

12 November 2017

James T Willerson

5

1 reference

12 November 2017

Ali J Marian

6

1 reference

12 November 2017

19 August 2010

1 reference

European Journal of Clinical Investigation

12 November 2017

1 reference

12 November 2017

40

1 reference

12 November 2017

11

1 reference

12 November 2017

976-983

1 reference

Tissue Doppler imaging consistently detects myocardial abnormalities in patients with hypertrophic cardiomyopathy and provides a novel means for an early diagnosis before and independently of hypertrophy

12 November 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2010.02349.X

Tissue Doppler imaging consistently detects myocardial contraction and relaxation abnormalities, irrespective of cardiac hypertrophy, in a transgenic rabbit model of human hypertrophic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2010.02349.X

Angiotensin II blockade reverses myocardial fibrosis in a transgenic mouse model of human hypertrophic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2010.02349.X

The L-type calcium channel inhibitor diltiazem prevents cardiomyopathy in a mouse model

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2010.02349.X

Idebenone treatment in Friedreich's ataxia: neurological, cardiac, and biochemical monitoring

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2010.02349.X

10.1111/J.1365-2362.2010.02349.X

21 January 2018

Identifiers

DOI

1 reference

12 November 2017

1 reference